Latest News

  • A $34 Smartphone Gadget That Can Detect HIV in 15 Minutes

    February 10, 2015 | When it comes to high risk, infectious diseases, early detection can make all the difference in getting ill patients some much needed treatment. In some cases, it may even help stem an outbreak. This becomes incredibly critical

    May 27, 2015
  • Blood Test for Early Cancer Detection

    February 22, 2015 | Among Tech Review's top breakthroughs of 2015 liquid biopsy. Fast DNA sequencing machines are leading to simple blood tests for cancer. Availability now MIT Technology Review

    May 27, 2015
  • Risk to Patients Balanced Against Risk to Labs as FDA Moves on Lab Developed Tests

    By Aaron Krol   September 23, 2014 | Nearly two months have passed since the FDA announced its intention to start regulating laboratory developed tests, or LDTs, by mid 2015. These tests, which are designed, made and performed entirely in a single

    May 27, 2015
  • What You Need to Know About the FDA's Push to Regulate Laboratory Developed Tests

    By Aaron Krol   August 1, 2014 | On Thursday afternoon, the FDA announced that it plans, for the first time, to regulate laboratory developed tests in the same way it does other diagnostics. Up until now, this particular type of test

    May 27, 2015
  • Big Changes for Molecular Diagnostics as FDA Moves on Lab Developed Tests

    By Aaron Krol   September 23, 2014 | Nearly two months have passed since the FDA announced its intention to start regulating laboratory developed tests, or LDTs, by mid 2015. These tests, which are designed, made and performed entirely in a single

    May 27, 2015
  • Quanterix Aims for Early Clinical Adoption with High-Throughput Protein Assays

    By Aaron Krol   January 2, 2015 | I came to the Simoa Accelerator, a small lab located inside the Quanterix headquarters in Lexington, Mass., at a good time the first experiment of the day had finished in the early afternoon, and

    May 27, 2015
  • Chinese Services Group WuXi Buys NextCODE Health for $65m

    Bio-IT World | WuXi PharmaTech headquartered in Shanghai has acquired NextCODE Health of Iceland for $65 million in cash. The acquisition will merge the WuXi Genome Center with NextCODE to form WuXi NextCODE Genomics. The business will be headquartered in Shanghai. 

    May 27, 2015
  • Foundation Medicine on the Added Value of NGS Cancer Tests

    Clinical Informatics News | Foundation Medicine of Cambridge, Mass., continues to make the case for expansive next generation sequencing (NGS) tests as the front line of cancer diagnostics, with a new publication in Clinical Cancer Research. 

    May 27, 2015
  • Foundation Medicine Majority Stake Acquired by Roche for $1.03b

    By Bio IT World Staff January 12, 2015 | Roche announced this morning that it has acquired a majority stake in Foundation Medicine. Roche will tender approximately $780m for 56.3% of the company and make an additional $250m investment by acquiring

    May 27, 2015
  • A Restless Illumina on Display in CEO's J.P. Morgan Address

    By Aaron Krol  January 13, 2015 | Yesterday, Illumina CEO Jay Flatley gave his annual address at the J.P. Morgan Healthcare Conference in San Francisco, one year after using his J.P. Morgan slot to announce the launch of the HiSeq X, the fastest

    May 27, 2015
  • SV Bio Relaunched as Lifecode, Maker of LDTs

    By Bio IT World Staff  January 20, 2015 | SV Bio today announced a new name, a new focus, and a new product a next generation sequencing (NGS) based oncology assay, the Pan Cancer Somatic Panel (PCSP). Silicon Valley Biosystems was

    May 27, 2015
  • QIAGEN Gets European Approval for Lung Cancer Liquid Biopsy

    By Clinical Informatics News Staff January 21, 2015 | QIAGEN’s circulating tumor DNA companion diagnostic for lung cancer has been granted CE IVD marking in 30 European countries, the company announced. The diagnostic is designed as a companion for Astra Zeneca’s

    May 27, 2015
  • Claritas Announces $15m Funding Round

    By Bio IT World Staff January 26, 2015 | Claritas Genomics announced today that it has secured $15 million in capital for its Series B round to expand its commercial operations, launch new next generation sequencing based tests for diagnosis of

    May 27, 2015
  • Appistry Launches CloudDx Translational from NIH Tool

    By Bio IT World Staff   January 26, 2015 | Appistry today launched Appistry CloudDx Translational, a “sister product” to the CloudDx platform launched last June, now renamed CloudDx Clinical. CloudDx Translational is a cloud based system for conducting patient centered translational research.

    May 27, 2015
  • A New Beginning for Semiconductor Sequencing

     By Aaron Krol   February 2, 2015 | In December 2010, Ion Torrent of Connecticut launched the first commercial product based on a new technology called semiconductor sequencing. The Ion PGM, sold at half the price of its nearest competitors, was taking

    May 27, 2015
  • Invitae Raises $102 Million for 'Universal' Genetic Test

    February 12, 2015 | Invitae, a genetic testing company founded by former Genomic Health CEO Randy Scott, raised $102 million today in an initial public offering. While many in the field of genomics have predicted that plummeting costs of DNA sequencing

    May 27, 2015
  • Humbled Myriad Caves on BRCA Patents

    By Aaron Krol   January 28, 2015 | The long courtroom fights are at long last coming to an end as Myriad Genetics has announced it will settle its complex web of suits and countersuits and end claims to ownership of certain

    May 27, 2015
  • BGI Releases Non-Invasive Prenatal Testing Results

    1 30 15 Additional details about the NIFTY test were added in paragraph four.    By Bio IT World StaffJanuary 29, 2015 | BGI published the results of its non invasive prenatal test, the NIFTY, this month in Ultrasound Obstetrics and Gynecology (DOI 10.1002

    May 27, 2015
  • Obama Announces $215m Precision Medicine Investment for NIH, FDA

    By Allison Proffitt   January 30, 2015 | President Obama will outline this morning his proposed investments to improve health and treat disease through precision medicine. The president will set out a $215m plan, “to build the infrastructure we need to accelerate

    May 27, 2015
  • Foundation Medicine and H3 Biomedicine Sign Oncology Agreement

    By Bio IT World Staff  February 23, 2015 | Foundation Medicine and H3 Biomedicine announced a multi year collaboration today for the discovery and development of precision medicines in oncology. The collaboration marries Foundation Medicine’s comprehensive genomic knowledgebase of more than 35,000 genomic profiles, FoundationCORE,

    May 27, 2015